“…Based on this, abundant research has been devoted to breast cancer treatment. , Unfortunately, only one of these pathways can be inhibited with a single agent, so the therapeutic effect was poor; − meanwhile, combination therapy offers the potential to simultaneously inhibit multiple targets and pathways to effectively kill cancer cells, ,− which may consequently cause multiple kinds of cell death pathways. Among all kinds of pathways, ferroptosis is a kind of iron-dependent programmed cell death, which is mainly caused by the abnormal increase of iron-dependent lipid oxygen free radicals in cells and imbalance of redox homeostasis. , The presence of Fe 2+ greatly accelerates the lipid peroxidation reaction of saturated fatty acids, − which produces reactive oxygen species (ROS) and then causes cell damage or death. , In addition, autophagy is a common cell death pathway too. Autophagy cell death is a process that means “self-digestion, end self” when cells are exposed to hunger or external stimuli; , furthermore, autophagy can degrade heavy chain ferritin 1 (FTH1) and release Fe 2+ , which could promote ferroptosis. , Due to the promoting effect of autophagy on ferroptosis, studies have shown that autophagy often cooperates with ferroptosis in tumor treatment.…”